Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
6,870.00    115.00 (1.70%)
Bid:
6,855.00
Ask:
6,860.00
Spread: 5.00 (0.073%)
Market Cap: £30.42b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

Changes in Committee Composition

22 May 2025 17:11

RNS Number : 8577J
Coca-Cola Europacific Partners plc
22 May 2025
 

 

CHANGES IN COMPOSITION OF THE BOARD COMMITTEES

 

The Board of Directors of Coca-Cola Europacific Partners plc (CCEP) announces the following changes to the composition of the Board Committees with effect from 23 May 2025:

 

· following his formal appointment as an Independent Non-executive Director at the 2025 Annual General Meeting held on 22 May 2025, Robert Appleby will be appointed as a member of the Audit Committee and as a member of the Environmental, Social and Governance Committee;

 

· Thomas H. Johnson will be appointed as Chairman of the Affiliated Transaction Committee; and

 

· Mark Price will step down as a member of the Environmental, Social and Governance Committee and will be appointed as a member of the Affiliated Transaction Committee.

 

 

Following the changes noted above, the membership of the affected Committees is as follows:

 

Audit Committee

Affiliated Transaction Committee

Environmental, Social and Governance Committee

Dessi Temperley (Chairman)

Thomas H. Johnson (Chairman)

Mario Rotllant (Chairman)

Robert Appleby

Sol Daurella

Robert Appleby

John Bryant

Nathalie Gaveau

Nathalie Gaveau

Nicolas Mirzayantz

Alfonso Libano Daurella

Nicolas Mirzayantz

Mark Price

Nancy Quan

 

 

CONTACTS

 

Company Secretariat

Clare Wardle

clare.wardle@ccep.com

Investor Relations

Sarah Willett

sarah.willett@ccep.com

Media Relations

Shanna Wendt

mediaenquiries@ccep.com

 

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ, London Stock Exchange and on the Spanish Stock Exchanges, and a constituent of both the NASDAQ 100 and FTSE 100 indices, trading under the symbol CCEP.

For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUBCAUPAGAP
Date   Source Headline
27th May 202112:00 pmRNSResult of AGM
20th May 20211:00 pmRNSDirector/PDMR Shareholding
13th May 20212:45 pmRNSLetter to Shareholders
11th May 202112:30 pmRNSInvestor event following acquisition of Amatil
11th May 20217:00 amRNSQ1 2021 Trading Update
10th May 202111:00 amRNSChange of Name
4th May 20212:00 pmRNSTotal Voting Rights
27th Apr 20214:36 pmRNSPrice Monitoring Extension
21st Apr 20215:30 pmRNSDirector/PDMR Shareholding
21st Apr 20217:00 amRNSAnnounces new company name and investor event
20th Apr 20218:10 amRNSCCEP Unaudited Pro Forma Combined Financial Info
15th Apr 20211:30 pmRNSNotice of AGM
15th Apr 20218:04 amRNSCCEP confirms regulatory approval from NZ OIO
13th Apr 202111:00 amRNSDirectorate Change
1st Apr 20213:00 pmRNSTotal Voting Rights
31st Mar 20213:22 pmRNSUpdate re Coca-Cola Amatil Financing
24th Mar 202112:00 pmRNSDirector/PDMR Shareholding
17th Mar 20216:00 pmRNSDirector/PDMR Shareholding
17th Mar 20216:00 pmRNSBlock listing Interim Review
12th Mar 20215:31 pmRNSAnnual Financial Report
12th Mar 20217:00 amRNSScheme booklet registered by Coca-Cola Amatil
1st Mar 20214:00 pmRNSTotal Voting Rights
24th Feb 202111:00 amRNSDirector/PDMR Shareholding
15th Feb 20217:00 amRNSBest and final offer to acquire Coca-Cola Amatil
11th Feb 20217:00 amRNSPreliminary Unaudited Results Q4 & FY 2020
1st Feb 20213:00 pmRNSTotal Voting Rights
1st Feb 20217:00 amRNSCCEP receives FIRB approval to acquire CCL
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
21st Jan 202111:00 amRNSDirector/PDMR Shareholding
4th Jan 20212:30 pmRNSTotal Voting Rights
4th Jan 20211:30 pmRNSCoca-Cola European Partners plc Home Member State
23rd Dec 20201:00 pmRNSDirector/PDMR Shareholding
14th Dec 20204:30 pmRNSDirector/PDMR Shareholding
11th Dec 202011:30 amRNSDirector/PDMR Shareholding
1st Dec 20205:15 pmRNSTotal Voting Rights
1st Dec 20205:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20201:45 pmRNSDirector/PDMR Shareholding
11th Nov 20205:30 pmRNSDirector/PDMR Shareholding
4th Nov 20207:00 amRNSUpdate re Coca-Cola Amatil acquisition
2nd Nov 20204:00 pmRNSTotal Voting Rights
29th Oct 20205:45 pmRNSDirector/PDMR Shareholding
26th Oct 20207:05 amRNSQ3 Trading Update & Interim Dividend Declaration
26th Oct 20207:00 amRNSProposed acquisition of Coca-Cola Amatil
22nd Oct 20201:00 pmRNSDirectorate Change
20th Oct 20203:00 pmRNSDirector/PDMR Shareholding
6th Oct 20205:00 pmRNSDirector/PDMR Shareholding
1st Oct 20205:10 pmRNSTotal Voting Rights
23rd Sep 202011:00 amRNSDirector/PDMR Shareholding
17th Sep 20202:00 pmRNSBlock listing Interim Review
14th Sep 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.